可生物降解的协调纳米药物可以增强光动力疗法和肺癌免疫疗法

Jingyao Li1, Huixi Yi1, Yuanyuan Fu1

  • 1Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, The Fifth Affiliated Hospital and School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China.

概括

这项研究引入了与协调的新型纳米药物,可以对抗瘤缺氧和免疫抑制. 这些纳米药物增强光动力疗法 (PDT) 和免疫疗法,导致显著的瘤抑制,毒性最小.